Subject : Strategic investment for Polysilicon CrystalsManufacturing
Let me introduce myself. I am Sr. Vice President, M/S.Nectar Lifesciences Ltd. (NLL), Chandigarh (India), which is engaged primarilyin the business of manufacturing & marketing of lifesciences products particularly antibacterials i.e. cephalosporin’swith 40% market share in Indian & rest of the world (ROW) markets.
NLL is the largest manufacturers of Cefixime Trihydrate inthe world & second largest in case of Cefuroxime Axetil & Ceftriaxone Sodium Sterile with a global 3rd rank in caseof Cefpodoxime Proxetil. NLL features amongst the top fastest growing Asianpharma players & is actively involved in Contract Research & Manufacturing Services (CRAMS).
NLL has identified Polysilicon Crystals Manufacturing asa new area for diversification. Accordingly we’re proposing to invest in thishigh technology areas of strategic investment. This investment will compriseof initial infusion of INR 500-750Crores (USD 110-175 Million) to set up a state of art PowerPlant with latest technology with emphasis on efficiency of conversion.
We are looking for a Plant of up to 1000-1500 TPA in Northof India, preferably in the state of Punjab. In second Phase, we would like to infuse additional USD 825-890Million in a period of 3 years from now for upgrading the capacity to4000-5000 TPA.
We would greatly appreciate if you could kindly send us your offer for theturnkey supply of a latest technology based Polysilicon Crystals ManufacturingPlant of a capacity as mentioned above with highest possibleefficiency and with the best environment friendly technology.
Awaiting for your kind revert.
With Best Regards,
Sr. Vice President Projects,
M/S Nectar Lifesciences Ltd.,
SCO. 38-39, Sector 9-D,